AXP vs SLS · P/E 20, rev $21.73B vs $1.62B cap
American Express Company (AXP) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. SLS currently screens at market cap $1.62B.
Not investment advice. Open the AXP and SLS stock pages for the full models.
Not investment advice.